Our team at Pharmafocuseurope.com believes that press releases are an important marketing tool for highlighting a client's corporate message and ensuring it reaches their target audience. The feature can be used to publish business agreements, annual reports, financial results, corporate performances, important announcements, and any other important information that needs to be communicated to the target audience. Pharma companies can also use it to launch new products and promote existing ones.
Collegium Pharmaceutical Inc a leading diversified specialty pharmaceutical company committed to improving the lives of people living with serious medical
Deciphera Pharmaceuticals Inc a biopharmaceutical company focused on discovering developing and commercializing important new medicines to improve the lives of people with cancer today announced that it has entered
Idorsia Ltd announced today that the Committee for Medicinal Products for Human Use the scientific committee of the European Medicines Agency adopted a positive opinion for the use of JERAYGO
Sino Biological Inc a biotechnology company listed on the Shenzhen stock exchange subsidiary ChiNext specializing in biological research reagents
Starton Therapeutics Inc a clinicalstage biotechnology company transforming standardofcare therapies with proprietary dermal technologies announced today the successful completion of enrollment for its STARLLD Phase b clinical trial
Parexel one of the worlds largest clinical research organizations providing the full range of Phase I to IV clinical development services and Palantir Technologies Inc a leading builder of Artificial Intelligence systems today announced a multiyear
BioAffinity Technologies Inc a biotechnology company focused on the need for noninvasive accurate tests for the detection of earlystage lung cancer and other lung diseases today announced David Elzi PhD has been named Vice President
Arrowhead Pharmaceuticals Inc announced today that it has dosed the first subjects in a Phase a clinical trial of AROCFB the companys investigational RNA interference therapeutic in up to healthy volunteers and patients with complement
Medicure Inc a company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market announced today that through its subsidiary Medicure
Palisade Bio Inc a biopharmaceutical company focused on developing and advancing novel therapeutics for patients living with autoimmune inflammatory and fibrotic diseases today announced it has entered
